A dose-dependent decrease in infectivity was observed on introduction of eosinophils into suspensions of respiratory syncytial virus group B (RSV-B). This antiviral effect was reversed by ribonuclease inhibitor, suggesting a role for the eosinophil secretory ribonucleases. Recombinant eosinophil-derived neurotoxin (rhEDN), the major eosinophil ribonuclease, promoted a dose-dependent decrease in RSV-B infectivity, with a 40-fold reduction observed in response to 50 nM rhEDN. Ribonucleolytically inactivated rhEDN (rhEDNdK 38 ) had no antiviral activity. Semiquantitative reverse transcriptase -polymerase chain reaction demonstrated loss of viral genomic RNA in response to rhEDN, suggesting that this protein promotes the direct ribonucleolytic destruction of extracellular virions. Ribonuclease A had no antiviral activity even at Ç1000-fold higher concentrations, suggesting that rhEDN has unique features other than ribonuclease activity that are crucial to its effectiveness. These results suggest that rhEDN may have potential as a therapeutic agent for prevention or treatment of disease caused by RSV.
Although the involvement of eosinophils in the pathophysitarget cells by a ribonuclease-dependent mechanism [26] . In this work, we have focused on respiratory syncytial virus ology of allergic diseases and asthma has been studied extensively, the potential beneficial roles played by these cells re-(RSV), a major pathogen of the family Paramyxoviridae. There are a number of intriguing associations that link eosinophils, main poorly understood [1 -6] . Human eosinophils contain a number of distinct secretory effectors, including eosinophil pereosinophil granule proteins, asthma and allergic bronchospasm, and respiratory disease caused by RSV [27 -38] . For example, oxidase, major basic protein, eosinophil-derived neurotoxin (EDN), and eosinophil cationic protein (ECP) [6, 7] . EDN and several groups have shown that during RSV infection, eosinophils are recruited to and degranulate into the lung parenchyma ECP are closely related proteins that have ribonuclease activity [8, 9] and that are members of the RNase A superfamily [10 - [31 -34] , and wheezing during RSV infection is associated with increased concentrations of ECP in respiratory secretions [31] . 15]. EDN/RNase 2, the major eosinophil ribonuclease, is 100-fold more ribonucleolytically active than ECP/RNase 3 [8] , Most dramatically, children previously vaccinated with a formalin-inactivated RSV vaccine who subsequently developed and although EDN displays specific neurotoxic activity when injected directly into the central nervous systems of experimennatural RSV infection had increased blood eosinophil counts tal animals [16 -19] , it has no defined physiologic role. A [39] , and massive eosinophil infiltrates were observed in postnumber of recent studies have suggested that EDN's ribomortem specimens of vaccinated children who died of RSV nuclease activity is likely to be of primary importance to its pneumonia [40] . While the role of eosinophils in host defense as-yet-undetermined function [15, 20, 21] . These findings, toagainst RSV remains speculative, these studies demonstrate gether with others relating to ribonucleases and viral infection that recruitment of eosinophils to the respiratory tract can and [22 -25], have prompted us to consider the possibility that does occur in response to RSV infection and, when exaggereosinophil secretory ribonucleases could promote the destrucated, may lead to a more severe form of RSV disease. tion of single-stranded RNA viruses.
In this work, we investigated whether the inherent antiviral In an initial investigation of this hypothesis, we demonstrated activity of eosinophils was due to the actions of their secrethat eosinophils can inhibit retroviral transduction of human tory ribonucleases, particularly the major eosinophil ribonuclease, EDN.
terms of infectious units per milliliter; we have defined an infectious unit as the component within the virus suspension that results in the detectable infection of a single cell in the confluent monolayer.
In figure 1 we demonstrate that there is a linear relationship (r 2 Å .987) between the number of infected HEp-2 cells in a confluent monolayer (3-4 1 10 5 cells/monolayer) and the dilution of virus suspension within the range used for our experiments. We have compared our measure of virus infectivity with that obtained from the traditional plaque assay [41] and found a close correlation between the number of plaque-forming units and number of infectious units as defined here in a given volume of virus suspension (e.g, 1.8 1 10 5 pfu/mL by standard plaque assay vs. 1.9 1 10 5 pfu/mL by quantitative shell vial assay). The correlation has been confirmed over a broad range of concentrations. Eosinophil isolation. Peripheral blood eosinophils were freshly isolated from normal volunteers by CD16 negative selection as described [42, 43] . Briefly, 60 mL of peripheral blood per isolation was subjected to ficoll-hypaque density centrifugation (Organon Teknika, Durham, NC), and the erythrocytes comigrating with the granulocyte pellet were lysed with ACK lysing buffer (BioWhittaker, Walkersville, MD). Granulocytes washed twice neutrophils and mononuclear cell fractions were freshly isolated cells, maintained in Eagle MEM / 10% fetal bovine serum, were from normal volunteers by ficoll-hypaque density centrifugation obtained from Viromed (Minneapolis). RSV-A and RSV-B were (Organon Teknika). The mononuclear cell fraction was harvested, used to inoculate 180-cm 2 flasks containing semiconfluent monoand the erythrocytes comigrating with the granulocyte pellet were layers of HEp-2 cells, and PIV-1, -2, and -3 were used to inoculate lysed with ACK lysing buffer (BioWhittaker). The two different monolayers of RhMk cells, each in 50 mL of maintenance medium.
leukocyte fractions were washed twice with and resuspended in When cytopathic effect reached Ç80%, the supernatants were har-PBE as described for eosinophils. The neutrophil fractions convested, centrifuged at 2000 rpm to remove cellular debris, and tained õ2% eosinophils as determined by Diff-Quik staining flash-frozen in 1-mL aliquots (virus suspension).
(Fisher Scientific).
Quantitative shell vial assay of virus infectivity. We have
Preparation of recombinant human (rh) proteins rhEDN and adapted shell vial technology, more commonly used in clinical ribonucleolytically inactivated rhEDN (rhEDNdK 38 ). Creation of diagnostic laboratories, for the experiments described here. Our the recombinant plasmid constructs (pFLAG-CTS; International assay permits more rapid evaluation of changes in virus infectivity Biotechnologies, New Haven, CT) and preparation of the recombithan can be achieved with the traditional plaque assay (24 h vs. 8 nant protein was as previously described [20] . Briefly, recombinant days); the dose-response curve is discussed below and also in figure proteins were isolated from 2-4 L of bacterial culture after a 1-h 1. Shell vials (4 mL) containing round coverslips with confluent induction with isopropyl-1-thio-b-galactoside. After harvest and monolayers of the appropriate target cell line (HEp-2 for RSV, sucrose lysis, recombinant proteins were concentrated and isolated RhMk for PIV) were obtained from Viromed. Shell vials were by M2 monoclonal antibody-agarose affinity chromatography (Ininoculated with 200 mL of virus suspension from each experimenternational Biotechnologies). The concentration of recombinant tal condition, then centrifuged at 700 g at 22ЊC for 1 h to amplify proteins was determined by comparison with serial dilutions of a the infection. One milliliter of maintenance medium was added, known concentration of FLAG-conjugated standard as described and the shell vials were incubated at 37ЊC for 16 h. Monolayers [20] . Some of the rhEDN used was prepared in Sf9 cells via were washed and fixed with cold acetone for 20 min. Immunofluoinserting the full-length EDN cDNA [12] and C-terminal FLAG rescence staining was done with mouse anti-RSV blend fluorescein into the pVL1393 expression vector (InVitrogen, San Diego), isothiocyanate-labeled monoclonal antibodies (Chemicon Internawhich was used together with the AcNPV wild type baculovirus tional, Temecula, CA). Stained coverslips were mounted onto DNA to cotransfect as described [44] . /mL) and ribonuclease with random hexamer priming. Forty-cycle PCR was done on serial activities measured in virus suspensions to which eosinophils were dilutions of cDNA with RSV G protein-specific 5 and 3 primers added and subsequently removed.
as described [45] . The PCR products were separated by 2.5% agarose gel electrophoresis, and the single amplification product to maintain isotonicity.
The data in table 2 demonstrate that the Ç4-fold reduction Ribonuclease assay. Ribonuclease assay was done as dein virus infectivity resulting from the introduction of 0.4 1 10 6 scribed in detail [20] . Reactions were initiated with 40 mg of yeast eosinophils/mL into virus stocks of RSV-B was eliminated tRNA as substrate (Sigma, St. Louis) added to 0.8-mL reactions when placental ribonuclease inhibitor was included (P õ .01). containing 40 mM sodium phosphate, pH 7.0, and 10 mL of virus stocks treated with eosinophils, rhEDN, rhEDNdK 38 , or buffer controls. Reactions were stopped at given time points by the addi- Table 2 . RSV-B remaining after treatment of virus suspensions with tion of ice-cold 3% perchloric acid with 40 nM lanthanum nitrate, isolated human eosinophils, neutrophils, or mononuclear cells (at 4 and acid-soluble ribonucleotides remaining in the supernatant frac-1 10 6 /mL), and buffer control with or without ribonuclease inhibitor tion after centrifugation were quantitated spectrophotometrically (RI) at 200 U/mL. at 260 nM. All time points were tested in triplicate. Calculations included the following approximations: the average molecular 
Reverse transcriptase-polymerase chain reaction (RT-PCR).
Buffer / RI 2248 { 94 RNA was isolated from 1-mL volumes of virus stocks treated with 100 nM rhEDN or 100 nM rhEDNdK 38 Not only does this observation suggest that the ribonuclease We have extended our observations on eosinophil-mediated antiviral activity to include clinical isolates of RSV-A and activity released by the eosinophils is crucial to the antiviral effect, the fact that ribonuclease inhibitor alone can eliminate PIV-1, -2, and -3 (table 3) . As anticipated, virions of these paramyxoviruses display similar (although not identical) ribothe antiviral effect effectively rules out other mechanisms that might explain this phenomenon, such as nonspecific virus bindnuclease-dependent sensitivity to isolated human eosinophils; the PIVs display somewhat less sensitivity than either of the ing or incorporation by eosinophils. In addition, we determined that eosinophils themselves were not infected by RSV-B, as RSV isolates. The data in table 4 demonstrate that EDN, the major eosinodemonstrated by immunofluorescence staining after overnight incubation (data not shown). Isolated human neutrophils (0.4 phil ribonuclease, can act alone as an antiviral agent and that loss of virus infectivity (up to 40-fold) increases in direct pro-1 10 6 /mL) have a slight but statistically significant ability to impair RSV-B infectivity compared with control (P õ .05); portion to its concentration (0 -50 nM rhEDN). The ribonucleolytically inactivated rhEDNdK 38 , in which the active-site lysine however, the neutrophil-mediated reduction in infectivity was not reversed by ribonuclease inhibitor, suggesting a mechanism (K 38 ) of rhEDN was converted by site-directed mutagenesis to a catalytically inactive arginine residue [20] , displayed no distinct from that promoted by eosinophils. Mononuclear cells had no effect on RSV-B infectivity; similarly, no loss of RSVantiviral activity in this assay. This result indicates, as anticipated from our previous results with isolated eosinophils, that B infectivity was observed when virus stocks were pretreated with cells of the K562 (human erythroleukemia) or AML 3D10 the capacity for ribonuclease activity is crucial to antiviral activity. This observation is supported by the data in figure 2, (human promyelocytic leukemia [46] ) cell lines (data not shown).
in which loss of viral genomic RNA is observed in response to rhEDN but not in response to rhEDNdK 38 . Interestingly, no antiviral activity was observed in virus sus- Table 4 . Dose-dependent reduction in RSV-B infectivity in repensions treated with RNase A (bovine pancreatic ribosponse to rhEDN (0 -50 nM) and to ribonucleolytically inactivated nuclease) at concentrations ranging from 40 to 4000 nM (table   rhEDNdK 38 (36 nM) and in parainfluenza virus (PIV)-3 infectivity in response to 40 nM rhEDN. from RNA isolated from virions treated with 100 nM rhEDN or 100 research, the physiologic function of EDN remains unknown [6, 7] . Although EDN was shown to be similar first in amino figure 3 . Although both contain the characteristic reduce virus infectivity, this does not necessarily imply that eight structural cysteines and the histidine and lysine active EDN does work alone in the context of an eosinophil; in earlier site components, and both are potent ribonucleases [47] , there work, Klebanoff and Coombs [54] have shown that the granule is significant divergence in primary structure.
5). The ribonuclease activities measured in virus suspensions
protein eosinophil peroxidase also has isolated activity against clinical strains of human immunodeficiency virus (HIV)-1. In addition, the recombinant protein differs substantially from naDiscussion tive EDN, most notably in that it lacks the extensive glycosylaIn this work, we have demonstrated that isolated human tion characteristic of EDN both within granules and released eosinophils are active against virions of RSV-A and -B and from activated eosinophils [55, 56] . The combined ribonucleo-PIV-1, -2, and -3 via the actions of their secreted ribonucleases.
lytic, membrane-lytic, and oxidative properties of the four maWe have also shown that the major eosinophil ribonuclease, jor eosinophil granule proteins may each contribute to the anti-EDN, can function alone as an effective antiviral agent in this viral activity observed with human eosinophils. experimental system. The rhEDN-mediated antiviral effect is Our observation that RNase A, even at the highest concentradose-dependent in the nanomolar range and could not be replitions, promotes no loss in virus infectivity suggests that other cated by a ribonucleolytically inactivated form of the recombifeatures of EDN apart from its ribonuclease activity are crucial nant protein. Furthermore, we have shown that the related riboto its antiviral activity. Both EDN and RNase A are highly nuclease, RNase A, did not reduce virus infectivity even at active generalized ribonucleases, and both can readily digest 1000-fold-higher concentrations, suggesting that while riboRNAs extracted from multiple sources [57, 58] . However, nuclease activity may be crucial to antiviral activity, other EDN's ability to inactivate extracellular virions depends not unique features of rhEDN are clearly necessary for this effect.
only on its ribonuclease activity but also on its ability to peneAs the role of eosinophils in host defense against RSV trate the viral capsid and gain access to the viral RNA genome. The mechanism of this penetration is not readily apparent. remains controversial, it is premature to conclude that EDN 
